Topics:

Obesity

Obesity

Women with polycystic ovary syndrome (PCOS) are at increased risk for metabolic and heart diseases and nearly twice as likely to be hospitalized.

GLP-1 RA, T2DM, weight loss before bariatric surgery

Pre-surgical weight loss in obese patients with type 2 diabetes reduces perioperative risk. The dual benefits of GLP-1 agonists offer promise to this hard-to-treat population.

The new guidelines signal a shift toward aggressive treatment for obesity as a primary disease and following with treatment for comorbidites that do not respond to weight loss.

The odds of children becoming overweight go up with sleep-disordered breathing and short sleep duration, underscoring the need for early identification of these risk factors.

After sleeve gastrectomy, obese patients with type 2 DM who have less severe disease do better than those who have more advanced disease. Surgery should be encouraged sooner rather than later.

The need for diabetes and cardiac medications is reduced significantly in obese patients who undergo weight-loss surgery, and so are their costs.

Contrave, a combination of naltrexone and buproprion, has been approved for long-term weight loss management in overweight and obese adults.

Pages

Subscribe to Obesity on [sitename]

CME Center

Earn CME Credits for reading Psychiatric Times articles. Click here to go to our free online CME activities.

By clicking Accept, you agree to become a member of the UBM Medica Community.